Ambrisentan

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.11, Iss.4, 2011-08, pp. : 215-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ambrisentan

By Croxtall Jamie D. Keam Susan J.

Drugs, Vol. 68, Iss. 15, 2008-01 ,pp. : 2195-2204

Adis International

Access to resources Recommend Favorite

Pharmacokinetic evaluation of ambrisentan

By Buckley Mitchell S Wicks Laura M Staib Robin L Kirejczyk Anna K Varker Andrew S Gibson Jamie J Feldman Jeremy P

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 3, 2011-03 ,pp. : 371-380

Informa Healthcare

Access to resources Recommend Favorite

Ambrisentan: ARIES results are a good sign for PAH

Inpharma, Vol. 1, Iss. 1593, 2007-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Ambrisentan: a guide to its use in pulmonary arterial hypertension

By Behr Jürgen

Drugs & Therapy Perspectives, Vol. 25, Iss. 7, 2009-07 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Safety and efficacy evaluation of ambrisentan in pulmonary hypertension

By Vizza Carmine Dario Fedele Francesco Pezzuto Beatrice Rubin Lewis J.

Expert Opinion on Drug Safety, Vol. 11, Iss. 6, 2012-11 ,pp. : 1003-1011

Informa Healthcare

Access to resources Recommend Favorite